ResearcherUniversity of VirginiaActive in the last 2 years

Olivia Sears

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9987-7563; OpenAlex author ID A5048150283. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2026: 2 papers

Papers 2

Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. Co-author DOI 10.1016/j.surg.2026.110256 ↗
Focused Ultrasound in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Clinical Applications. Co-author DOI 10.3390/cancers18040574 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Allan Tsung · 2 shared papers, 2026 · strength 0.70
- Paper Focused Ultrasound in Pancreatic Ductal Adenocarcinoma: Mechanisms, Preclinical Evidence, and Emerging Clinical Applica… DOI 10.3390/cancers18040574 ↗
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
Samantha M. Ruff · 1 shared paper, 2026 · strength 0.32
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
Elio R. Bitar · 1 shared paper, 2026 · strength 0.32
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗
Mohamad N. El Moheb · 1 shared paper, 2026 · strength 0.32
- Paper Neoadjuvant therapy in frail patients with pancreatic cancer: Impact on surgical safety and outcomes. DOI 10.1016/j.surg.2026.110256 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.